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1. Introduction 
Gangliotetraosylceramide (formula in fig.2) was 
first characterized as a core structure of brain ganglio- 
sides [ 11. Much attention has been focused on this 
glycolipid as a cell surface marker. In the mouse it 
was shown both immunologically [2] and chemically 
[3] that gangliotetraosylceramide was present in 
mature splenic thymus-derived (T) lymphocytes but 
absent from most other lymphocytes. The level was 
lo-20-times that of thymus cells or neonatal splenic 
T cells [ 31, defining this glycolipid as a differentiation 
antigen [3,4]. Furthermore, in mouse mutants which 
lack natural killer cell-mediated cytotoxicity, which is 
normally present in mature cells, the level of ganglio- 
tetraosylceramide was low [3]. Antibodies to ganglio- 
tetraosylceramide abolished the natural killer activity 
[5-71 and enhanced the growth of lymphoma in vivo 
[7]. In the rat this glycolipid has been identified not 
only on T lymphocytes but on macrophages and 
eosinophilic cells as well [8,9]. 
In peripheral blood of man lymphocytes of 16 
patients with acute lymphoblastic leukemia stained 
positively with anti-gangliotetraosylceramide anti- 
bodies while 20 normal persons or patients with other 
disorders were negative [9]. Autoantibodies to this 
glycolipid were found in human thyroid disorders [lo] 
and in systemic lupus erythematosus disease [ 111. 
In [ 121 on mass spectrometric analysis of small 
intestinal glycolipids of several animal species ganglio- 
tetraosylceramide was proposed as a major glycolipid 
of mouse small intestine. Here, we substantiate this 
and demonstrate the localization of this glycolipid to 
the epithelial cell layer. 
2. Materials and methods 
Fresh small intestine from 19 mice of strain C57/ 
BLJ was scraped gently several times with a spoon in 
the cold. The mucosa scrapings (epithelial cells) and 
the residues after scraping were worked up for non- 
acid glycolipids mainly as in [ 131. Gangliotetraosyl- 
ceramide, a major compound of mouse small intestine 
[ 121, was purified from whole small intestine in acet- 
ylated form on a silicic acid column. The pure glyco- 
lipid (fig.1 A) was analysed for carbohydrate [ 141 and 
subjected to permethylation [ 151 and reduction [ 161. 
These derivatives were analysed by direct inlet mass 
spectrometry [ 121 and after degradation by gas chro- 
matography [ 171. The reduced derivative was also 
characterized by NMR spectroscopy [ 18-201. A ref- 
erence of gangliotetraosylceramide was prepared from 
human brain gangliosides by mild acid hydrolysis of 
the sialic acid [I]. 
For comparison non-acid glycolipids were also pre- 
pared from stomach and large intestine of the same 
animals. 
3. Results and discussion 
Fig.1 shows a thin-layer chromatogram of non-acid 
glycolipids of the mucosa scraping of small intestine 
(B, total 5.8 mg), the residue after scraping (C, total 
11.3 mg), stomach tissue (D, total 4.2 mg), and large 
intestinal tissue (E, total 8.3 mg). The epithelial cells 
of small intestine (B) contained mostly glucosyl- 
ceramide (see [ 121) and a glycolipid migrating in the 
6-sugar interval and earlier proposed to be ganglio- 
tetraosylceramide [121. The identity of this latter 
glycolipid was confirmed as follows after isolation. 
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Fig.1. Thin-Layer chromatogram of nonacid glycolipids of 
mucosa scraping of mouse small intestine (B, 20 pg), residue 
after scraping of mouse small intestine (C, 20 pg), mouse 
stomach tissue (D, 40 fig), mouse large intestine (E, 40 fig) 
and purified gangliotetraosylceramide of mouse small intes- 
tine (A). A Merck HPTLC precoated Si 60 plate was used and 
solvent was chloroform-methanol-water 60:35:8 (by vol.). 
Anisaldehyde was used for detection. The band marked x was 
a dialysis bag contaminant. 
The overall composition (lipophilic part and number 
of sugars) and sugar sequence were obtained by mass 
spectrometry of intact permethylated and permethyl- 
ated-reduced derivatives [ 121. Ions for the correct 
sequence are indicated at the ring formula of fig.2, 
with underlined figures for masses obtained from the 
reduced derivative (see also [ 121). The series of peaks 
at m/e 1185-1297 was evidence for 16-24 carbon 
hydroxy fatty acids with 22,23 and 24 carbon spe- 
cies in dominance, as shown by the relative intensity 
of peaks. Phytosphingosine was the major long-chain 
base. Degradation of the non-derivatized glycolipid 
and gas-liquid chromatography showed the presence 
of Glc, Gal and GalNAc but the absence of GlcNAc. 
Fig.2 shows gas chromatograms after degradation of 
the permethylated derivative (top) and the reduced 
derivative [ 171, results in agreement with the top for- 
mula of fig.2. The anomerity was finally established 
by NMR spectroscopy of the reduced derivative 
(fig.2). The identity of the 4 signals was concluded 
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Fig.2. The top formula shows the structure of gangliotetraosyl- 
ceramide concluded to be a major glycolipid of mouse small 
intestine (cf. fig.1). The simplified ring formula presents 
some fragments obtained from mass spectrometry of the 
permethylated (figures not underlined) and permethylated- 
reduced (figures underlined) derivative of purified glycolipid 
(see text and [ 121). The 2 gas-liquid chromatograms were 
obtained after degradation of 250 r,rg permethylated (top) or 
400 pg permethylated-reduced glycolipid. The conditions for 
analysis were about the same as those in 
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from comparison with data from [ 18-201 and from 
spectra of permethylated and reduced erivatives of
gangliotriaosyl- and gangliotetraosylceramide derived 
from brain gangliosides (unpublished). 
As shown in fig.1, the 2 major glycolipids of the 
epithelial cells (B), gl ucosylceramide and gangliotetra- 
osylceramide, are also major components of the resi- 
due after mucosa scraping (C). This is due to ineffec- 
tive removal of epithelial cells by the gentle scraping, 
a large part probably being left mainly in the crypt 
(cf. [ 131). The sharp band appearing just above gan- 
gliotetraosylceramide was concluded to be the 
Forssman glycolipid [ 121. The band just in front of 
the latter was proposed to have the sequence hexos- 
amine-hexose-hexose [12], although it migrated as 
a 4-sugar glycolipid. These 2 glycolipids being absent 
from sample B should derive from the non-epithelial 
residue. However, the ceramide of the triglycosyl- 
ceramide was of the more hydroxylated type as for 
epithelial cell glycolipids in contrast o the Forssman 
glycolipid [ 12 3. Therefore, the triglycosylceramide 
may be an epithelial cell component but localized to 
the crypt, which was probably not scraped off. Alter- 
natively, and more likely, the band proposed to be 
the triglycosylceramide [ 121 may be a mixture of 
mainly globotetraosylceramide and the triglycosyl- 
ceramide. Globotetraosylceramide which is expected 
to be a non-epithelial component [121 would then 
have sugar and fatty acid ions 30 mass units lower 
than those of corresponding species of the dominat- 
ing gangliotetraosylceramide andmay therefore have 
been overlooked [121. Also, this band had a mobility 
identical with globoside of human erythrocyte. The 
triglycosylceramide would then be the band of(B) 
(epithelial part) moving as the faster of the two bands 
of globoside in (C) (residue). 
It is of interest hat the stomach tissue(D) and large 
intestine (E) of fig.1 apparently lacked gangliotetra- 
osylceramide. Instead there was a more slow-moving 
band, which may be fucosylated gangliotetraosyl- 
ceramide. The formation of this from gangliotetra- 
osylceramide was shown to be induced in small intes- 
tine after conventionalization f germ-free mice 
[21,22]. A fucolipid was earlier detected by us but 
this was concluded to migrate as gangliotetraosyl- 
ceramide [12]. 
The 3-sugar glycolipid of large intestine (E) being 
absent from small intestine (B,C) may be trihexosyl- 
ceramide. In stomach (D) the monohexosylceramide 
(shown to be glucosylceramide onborate plates, see 
[ 121) and some more slow-moving compounds appar- 
ently had a less hydroxylated ceramide than those of 
large intestine. 
The finding of gangliotetraosylceramide as a major 
glycolipid of mouse small intestine [12,221 and local- 
ized to the epithelial cells may explain some findings 
referred to in section 1. In man it has been shown 
that Lewis activity of erythrocytes of Lewis geno- 
types appears first after birth as a result of uptake of 
Lewis glycolipids from plasma. The site of synthesis 
of these glycolipids has not been proved but small 
intestine is a probable tissue, where large amounts of 
Lewis glycolipids may exist in the epithelial cells 
[23]. Although the situation for gangliotetraosyl- 
ceramide changes in T cells is not clear [4] there may 
be an uptake of intestine-derived glycolipid onto 
T cells which has left thymus [3 1. It would therefore 
be of interest o see if mutant mice, which lack natu- 
ral killer cell activity and have low levels of ganglio- 
tetraosylceramide in their splenic T cells [3 1, also 
have a lowered amount of this glycolipid in their 
intestine. 
Immunofluorescence staining of mouse small intes- 
tine was used in [24] to show that gangliotetraosyl- 
ceramide was exclusively localized to the brush bor- 
der and basolateral membranes of epithelial cells and 
that Forssman glycolipid was present in the mesen- 
chymal tissue. This result is in accordance with our 
conclusions based on direct chemical analysis after 
mucosa scraping. 
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